(1) The following reentry benefits available under CAA vary based upon whether the eligible juvenile is preadjudication or postadjudication:
(a) Preadjudication benefits (section 5122 of CAA, 2023) include the following for eligible juveniles that are incarcerated in public institutions pending disposition:
(i) Medicaid and CHIP benefits; and
(ii) Reentry targeted case management (RTCM) if the individual is expected to be released in less than 90 days.
(b) Postadjudication benefits (section 5121 of CAA, 2023) include:
(i) Clinical assessment and evaluation for eligible juveniles (diagnostic services and medical, behavioral, and dental screenings) provided within 30 days prerelease or no later than one week postrelease; and
(ii) Thirty days of RTCM prerelease and for at least 30 days postrelease.
(2) Reentry services outlined in this section are identified as either mandatory or optional. Clients may choose whether to receive reentry services. Reentry services include:
(a) Mandatory services. Carceral facilities must provide the following:
(i) RTCM;
(ii) Reentry substance use disorder (SUD) treatment, including clinical assessment and evaluation to screen, assess, evaluate, and diagnose SUD and medications for SUD; and
(iii) Reentry pharmacy services at release, which include:
(A) Vaccines and vaccine administration;
(B) Provider-administered drugs and administration; and
(C) A 30-day supply of prescriptions and over-the-counter drugs covered within the apple health preferred drug list and pharmacy-supplied medical supplies, or a shorter supply:
(I) When required by applicable law, regulation, or agency policy; or
(II) As prescribed by a treating provider;
(iv) Preadjudication services for eligible juveniles, which include services available under the client's program benefit package, as defined in WAC 182-501-0060, when appropriate to provide in a carceral setting; and
(v) Postadjudication services for eligible juveniles, which include clinical assessment and evaluation to screen, assess, evaluate, and diagnose health conditions in addition to the other mandatory services listed in this section; and
(b) Optional services. Carceral facilities may choose to provide the following reentry services:
(i) Ninety days prerelease pharmacy services, which include vaccines and vaccine administration, provider-administered drugs and administration, and prescriptions and over-the-counter drugs covered within the apple health preferred drug list and pharmacy-supplied medical supplies;
(ii) Laboratory services;
(iii) Radiology services;
(iv) Services by providers with lived experience;
(v) Clinical assessment and evaluation to screen, assess, evaluate, and diagnose health conditions for clients age 21 and older who are not CAA eligible; and
(vi) Medical equipment and supplies not covered by the mandatory reentry services.
(3) For the purposes of this chapter, services not listed in this section are not covered and are not eligible for approval under exception to rule under WAC 182-501-0160(2).